SLD Clinical Trials Programme
The 3rd and last edition of the ELPA SLD Clinical Trials training kicked off in Milan in June 2024.
The last cohort of ELPA members, composed of 8 participants from 7 countries, successfully started the programme. The training focused on equipping participants with advanced knowledge and practical skills essential for understanding and engaging in clinical trials in this critical area of liver health. The conclusion of this program marks a significant milestone in ELPA’s ongoing efforts to increase its members’ knowledge and involvement in drug development and ultimately combat liver disease through education and research.